morpheaform basal cell carcinoma
morpheaform basal cell carcinoma
Explore linked clinical trials. Standard reference: MONDO:00029491 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue | Neoplasms by Histologic Type, basal cell carcinoma, basal cell neoplasm, carcinoma, epithelial neoplasm, morpheaform basal cell carcinoma, neoplasm | Enrolling by invitation | Phase 3 | 2026-01-06 | NCT07311070 |